Biorce
The AI platform accelerating clinical trials
San Francisco Bay Area, Portugal · Founded 2024 · $47.5M raised
- Headquarters
- San Francisco Bay Area
- Employees
- 51–200
- Founded
- 2024
- Business Model
- B2B
- Website
- biorce.com
- Total Funding
- $47.5M
- Last Round
- $47.5M Series AMar 2025
- Rounds
- 1
About
Biorce is a Barcelona-based AI clinical trials platform company. Its flagship product, Aika, is an AI-native platform that unifies protocol design, feasibility analysis, and regulatory planning for clinical trials. Built on data from approximately one million real clinical trials, Aika provides explainable AI to help pharmaceutical sponsors and CROs accelerate trial setup, reduce protocol amendments, and cut trial costs by over 50%. Founded in 2024 by Pedro Coelho, Clara Bernardes, José Faria, and Diogo Pisoeiro, Biorce raised $52M in a Series A led by DST Global.
Summary
Biorce is a Healthcare company based in San Francisco Bay Area, Portugal, founded in 2024. It has raised $47.5M in total across 1 round, most recently a $47.5M Series A round in Mar 2025.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2025
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...